| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 1.109 | 7.819 | 5.061 | 8.044 | 10.549 | 5.832 | 760 | 3.516 | 7.500 | 2.755 |
| Total Income - EUR | 1.109 | 7.819 | 5.061 | 10.956 | 10.932 | 5.906 | 2.640 | 11.763 | 6.322 | 2.755 |
| Total Expenses - EUR | 586 | 1.626 | 2.179 | 9.111 | 6.055 | 4.599 | 4.636 | 13.361 | 3.293 | 2.516 |
| Gross Profit/Loss - EUR | 523 | 6.192 | 2.882 | 1.845 | 4.877 | 1.307 | -1.996 | -1.598 | 3.029 | 239 |
| Net Profit/Loss - EUR | 490 | 5.958 | 2.730 | 1.517 | 4.544 | 1.132 | -2.019 | -1.974 | 2.546 | 201 |
| Employees | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Marvis-Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 18 | 595 | 292 | 1.932 | 24.224 | 785 | 1.276 | 624 |
| Current Assets | 1.033 | 6.989 | 4.698 | 5.531 | 10.656 | 10.057 | 1.285 | 15.022 | 7.153 | 7.546 |
| Inventories | 61 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 175 | 1.600 | 2.340 | 2.373 | 2.194 | 89 | 368 | 11.090 | 1.237 | 514 |
| Cash | 797 | 5.389 | 2.359 | 3.158 | 8.462 | 9.968 | 917 | 3.932 | 5.915 | 7.032 |
| Shareholders Funds | -258 | 5.702 | 2.774 | 4.240 | 8.702 | 9.669 | 7.436 | 5.485 | 8.014 | 8.170 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 1.291 | 1.287 | 1.943 | 1.886 | 2.247 | 393 | 7.455 | 9.542 | 415 | 0 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 1.927 | 10.618 | 781 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "6210 - 6210" | |||||||||
| CAEN Financial Year |
6201
|
|||||||||
Comments - Marvis-Med Srl